Remicade Biosimilars Market Growing Market Share Accelerated by Increased Competition

Remicade biosimilars are increasingly being adopted for treating autoimmune and inflammatory diseases such as rheumatoid arthritis, Crohn's disease, and ulcerative colitis. Their therapeutic equivalence to reference biologics enables patients to achieve similar clinical benefits at lower costs. 

Market key trends:

Increased competition among biosimilar manufacturers has accelerated the growth of market share for Remicade biosimilars in recent years. The introduction of multiple competing biosimilar products at significant discounts to the reference biologic has compelled healthcare payers to prefer their adoption over branded Remicade. Several leading biosimilar makers have substantially ramped up their commercialization efforts targeting both developed and developing regions to gain higher penetration. This has enhanced accessibility and lowered treatment costs for a broader patient pool globally.

Segment Analysis

The global Remicade biosimilars market is dominated by the rheumatoid arthritis sub segment. This is because Remicade is primarily used for the treatment of autoimmune diseases like rheumatoid arthritis and Crohn's disease. It is one of the most prescribed biologics worldwide for rheumatoid arthritis treatment. As biosimilars offer cost saving benefits compared to the original biologic, their uptake has been high in the rheumatoid arthritis segment.

Key Takeaways

The Global Remicade Biosimilars Market Demand is expected to witness high growth over the forecast period driven by the expiry of Remicade's patents.

Regional analysis: Europe currently dominates the global market and is expected to continue its dominance during the forecast period. Higher acceptance and prescription of biosimilars along with early commercialization of biosimilar versions of Remicade in countries like Germany, UK, France etc. has contributed to Europe's large share.

Key players operating in the Remicade biosimilars market are Celltrion, Pfizer (Hospira), Synthon Pharmaceuticals, LG Life Sciences, Biogen idec Inc, Teva Pharmaceutical Industries, Biocon, Dr Reddy's Laboratories, Celltrion, Accord Healthcare.

Explore more information on this topic, Please visit - 

https://www.insightprobing.com/remicade-biosimilars-market-forecasts-and-outlook-analysis/